CRDF fundamentals
An in-depth look to Cardiff Oncology, Inc. operating, investing, and financing activities
CRDF free cash flow for Q4 23 is -7.15 M USD. For 2023, CRDF free cash flow was -31.47 M USD and operating cash flow was -30.89 M USD.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM